<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ischemic cerebral <z:mpath ids='MPATH_124'>infarcts</z:mpath> induce hypercoagulation and microthrombosis in the surrounding region, thus leading to <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We determined whether microthrombi contribute to the spreading of ischemic lesions following thrombotic middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) occlusion and also determined whether argatroban, a selective thrombin inhibitor, reduces the formation of the microthrombi and the area of the ischemic lesions </plain></SENT>
<SENT sid="2" pm="."><plain>The rat left <z:chebi fb="70" ids="34342">MCA</z:chebi> was occluded by a platelet-rich <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formed following the photochemical reaction between <z:chebi fb="0" ids="52261">rose bengal</z:chebi> and green light </plain></SENT>
<SENT sid="3" pm="."><plain>Microthrombi were histologically identified in the left hemisphere </plain></SENT>
<SENT sid="4" pm="."><plain>The extent of ischemic lesions and microthrombi containing fibrin increased in a time-dependent manner after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion </plain></SENT>
<SENT sid="5" pm="."><plain>Argatroban inhibited the formation of microthrombi up to 3 hr after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion; beyond 3 hr, it was ineffective </plain></SENT>
<SENT sid="6" pm="."><plain>Argatroban also significantly (P &lt; 0.01) reduced the size of ischemic <z:e sem="disease" ids="C0221505" disease_type="Disease or Syndrome" abbrv="">cerebral lesions</z:e> at 6 hr after <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion </plain></SENT>
<SENT sid="7" pm="."><plain>It is concluded that the formation of microthrombi contributes to the progression of ischemic lesions in the early stage </plain></SENT>
<SENT sid="8" pm="."><plain>It is likely that thrombin generated following thrombotic <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion contributes to the progression of ischemic lesions by promoting the formation of microthrombi </plain></SENT>
<SENT sid="9" pm="."><plain>Argatroban can reduce the formation of microthrombi and ischemic lesions in the early stage </plain></SENT>
</text></document>